On September 7, according to TASS news agency, British American Tobacco has announced the sale of its business in Russia and Belarus. However, the company's trademarks will continue to be owned by the Russian business. This news has been confirmed by the Russian branch of the company, as per their press release.
British American Tobacco announced today that it has completed the sale of its business operations in Russia and Belarus. All current trademarks will be retained by the Russian operations. As a result, consumers will continue to benefit from high-quality products under their familiar brands.
According to the information provided in the press release, the new business structure will be named ITMS Group after the completion of the transaction.
The buyers consist of a consortium of Russian investors and the local management team of "BAT Russia". The company's press release further states:
After completing all necessary procedures, the consortium will fully own the operations of British American Tobacco Group in Russia and Belarus.
The new business owner's main focus is to ensure continuity of all business processes throughout and after the transfer, secure employment opportunities for all employees, and adhere to an investment plan agreed upon in consultation with government officials.
In February 2023, the company announced its plans to complete the sale of its operations in Russia and Belarus by the end of this year.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
